We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$22.5B
AUM Growth
+$1.93B
(+9.4%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
1,346
New
164
Increased
337
Reduced
605
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$426M |
| 2 |
Deere & Co
DE
|
+$212M |
| 3 |
NVIDIA
NVDA
|
+$149M |
| 4 |
W.W. Grainger
GWW
|
+$140M |
| 5 |
Netflix
NFLX
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$196M |
| 2 |
Home Depot
HD
|
+$189M |
| 3 |
Gilead Sciences
GILD
|
+$145M |
| 4 |
Oracle
ORCL
|
+$145M |
| 5 |
Microsoft
MSFT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.24% |
| 2 | Financials | 13.5% |
| 3 | Healthcare | 12.02% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VMEO
851
DELISTED
Vimeo
VMEO
| $509K | ﹤0.01% |
132,820
+2,862
| +2% | +$11.2K |
|
852
BancFirst
BANF
$3.89B
| $508K | ﹤0.01% |
6,111
-8,116
| -57% | -$699K |
|
853
Equity Lifestyle Properties
ELS
$12.6B
| $506K | ﹤0.01% |
+7,536
| New | +$512K |
|
854
Utah Medical Products
UTMD
$230M
| $499K | ﹤0.01% |
5,262
-275
| -5% | -$25.3K |
|
855
Clean Harbors
CLH
$16.9B
| $494K | ﹤0.01% |
3,465
+420
| +14% | +$54.7K |
|
856
American Tower
AMT
$81.2B
| $493K | ﹤0.01% |
2,414
-65
| -3% | -$13.6K |
|
857
Byline Bancorp
BY
$1.78B
| $492K | ﹤0.01% |
22,760
-630
| -3% | -$14.7K |
|
858
Playtika
PLTK
$961M
| $491K | ﹤0.01% |
43,630
+2,460
| +6% | +$24.7K |
|
859
Reliance Steel & Aluminium
RS
$21.7B
| $490K | ﹤0.01% |
+1,908
| New | +$449K |
|
860
Box
BOX
$4.66B
| $490K | ﹤0.01% |
18,283
-1,602
| -8% | -$48.3K |
|
861
ATI
ATI
$30.9B
| $486K | ﹤0.01% |
12,311
+4,907
| +66% | +$185K |
|
862
Remitly
RELY
$5.39B
| $484K | ﹤0.01% |
28,566
-2,832
| -9% | -$38.5K |
|
863
Acadia Pharmaceuticals
ACAD
$4.89B
| $479K | ﹤0.01% |
+25,444
| New | +$485K |
|
864
Golar LNG
GLNG
$5.21B
| $478K | ﹤0.01% |
22,132
+1,583
| +8% | +$35.4K |
|
|
SPNS
865
DELISTED
Sapiens International
SPNS
| $478K | ﹤0.01% |
21,992
-2,140
| -9% | -$45.2K |
|
866
Frontdoor
FTDR
$5.83B
| $477K | ﹤0.01% |
+17,106
| New | +$452K |
|
867
S&T Bancorp
STBA
$1.82B
| $475K | ﹤0.01% |
15,112
-565
| -4% | -$19.7K |
|
868
Arrow Electronics
ARW
$10.6B
| $474K | ﹤0.01% |
3,798
-34,690
| -90% | -$4.11M |
|
869
Castle Biosciences
CSTL
$933M
| $474K | ﹤0.01% |
20,863
-773
| -4% | -$18.9K |
|
870
Radian Group
RDN
$4.92B
| $470K | ﹤0.01% |
21,281
-1,600
| -7% | -$34.1K |
|
871
Vishay Intertechnology
VSH
$5.11B
| $470K | ﹤0.01% |
20,774
-4,481
| -18% | -$98.5K |
|
|
SCHW
872
Charles Schwab
SCHW
$190B
| $466K | ﹤0.01% |
8,892
-175
| -2% | -$12.8K |
|
873
Berkshire Hathaway Class A
BRK.A
$1.09T
| $466K | ﹤0.01% |
1
-1
| -50% | -$467K |
|
874
Curtiss-Wright
CW
$25.4B
| $464K | ﹤0.01% |
2,631
-382
| -13% | -$64.7K |
|
875
City Holding Co
CHCO
$2.08B
| $461K | ﹤0.01% |
5,076
-427
| -8% | -$40.4K |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Los Angeles Capital Management held 1,346 positions worth $22.5B, up 9.4% from $20.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Los Angeles Capital Management's Q1 2023 filing shows 164 new, 337 increased, 605 reduced and 194 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M. The largest sale was Pfizer, an estimated $196M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Los Angeles Capital Management's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M.
- Los Angeles Capital Management added most to Visa in Q1 2023, an estimated $426M increase.
- Los Angeles Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $196M.
- Los Angeles Capital Management fully exited Regions Financial in Q1 2023, selling an estimated $50.4M.
- Los Angeles Capital Management's ten largest holdings make up 27% of its $22.5B portfolio in Q1 2023.
- Los Angeles Capital Management opened 164 new positions and closed 194 in Q1 2023.
- Los Angeles Capital Management's portfolio value rose 9.4% quarter-over-quarter to $22.5B.
Based on Los Angeles Capital Management's 13F filing for Q1 2023, filed 4 May 2023.